Filtered By:
Condition: Diabetes
Management: Department of Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 20 results found since Jan 2013.

IJERPH, Vol. 20, Pages 5799: Retrospective Analysis of the Outcome of Hospitalized COVID-19 Patients with Coexisting Metabolic Syndrome and HIV Using Multinomial Logistic Regression
ua Modjadji Globally, the coexistence of metabolic syndrome (MetS) and HIV has become an important public health problem, putting coronavirus disease 19 (COVID-19) hospitalized patients at risk for severe manifestations and higher mortality. A retrospective cross-sectional analysis was conducted to identify factors and determine their relationships with hospitalization outcomes for COVID-19 patients using secondary data from the Department of Health in Limpopo Province, South Africa. The study included 15,151 patient clinical records of laboratory-confirmed COVID-19 cases. Data on MetS was extracted in the form of a cl...
Source: International Journal of Environmental Research and Public Health - May 12, 2023 Category: Environmental Health Authors: Peter M. Mphekgwana Musa E. Sono-Setati Tania V. Mokgophi Yehenew G. Kifle Sphiwe Madiba Perpetua Modjadji Tags: Article Source Type: research

Weekly Overseas Health IT Links –17th September, 2022.
This study adds to the evidence showing that expanded access to these services could have a longer-term positive impact if continued.”Roughly 1 in 8 beneficiaries in the pandemic group received OUD-related telehealth services compared with 1 in 800 in the prepandemic group, the research revealed. Access to telehealth services was associated with better treatment retention and lower risk of medically treated overdose in the pandemic group compared to those not receiving telehealth services.-----https://healthimaging.com/topics/management/education-training/ai-deterring-students-pursuing-radiologyConcerns about the future ...
Source: Australian Health Information Technology - September 17, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

Weekly Overseas Health IT Links –10th September, 2022.
This article is adapted fromVoices in the Code: A Story About People, Their Values, and the Algorithm They Made,out Sept. 8 from Russell Sage Foundation Press.In May 2021, I got a call I never expected. I was working on abook about A.I. ethics, focused on the algorithm that gives out kidneys to transplant patients in the United States. Darren Stewart —a data scientist from UNOS, the nonprofit that runs the kidney allocation process—was calling to get my take: How many decimal places should they include when calculating each patient’s allocation score? The score is an incredibly important number, given it determines w...
Source: Australian Health Information Technology - September 10, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

The New $10 Billion COVID-19 Deal Leaves Uninsured People at Risk
When Senators announced on Monday that they reached a deal for $10 billion in additional funding for the coronavirus response, many public health experts were dismayed that the package will not include aid for vaccines abroad. But another area that is likely to get shorted is the program that has covered the costs of coronavirus tests, treatments and vaccines for uninsured Americans. That lack of funding could not only hurt the most vulnerable Americans, experts say, but also fuel future outbreaks of COVID-19. The program for uninsured people began winding down late last month. The Biden Administration repeatedly asked la...
Source: TIME: Health - April 5, 2022 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 Source Type: news

NIH Director Francis S. Collins to Step Down by End of Year
Dr. Francis S. Collins, director of the National Institutes of Health for 12 years, said Tuesday he is stepping down, capping a career in which he directed crucial research into the human genome and the fight against serious diseases like cancer, Alzheimer’s, diabetes and COVID-19. Collins said he was “grateful and proud of the NIH staff and the scientific community, whose extraordinary commitment to lifesaving research delivers hope to the American people and the world every day.” He said the decision to step down at year’s end was “a difficult one.” “I fundamentally believe, howe...
Source: TIME: Health - October 5, 2021 Category: Consumer Health News Authors: DINO HAZELL/AP Tags: Uncategorized Public Health wire Source Type: news

Characteristics, Comorbidities, and Data Gaps for Coronavirus Disease Deaths, Tennessee, USA
Emerg Infect Dis. 2021 Oct;27(10):2521-2528. doi: 10.3201/eid2710.211070.ABSTRACTAs of March 2021, coronavirus disease (COVID-19) had led to >500,000 deaths in the United States, and the state of Tennessee had the fifth highest number of cases per capita. We reviewed the Tennessee Department of Health COVID-19 surveillance and chart-abstraction data during March 15‒August 15, 2020. Patients who died from COVID-19 were more likely to be older, male, and Black and to have underlying conditions (hereafter comorbidities) than case-patients who survived. We found 30.4% of surviving case-patients and 20.3% of deceased patie...
Source: Emerging Infectious Diseases - September 21, 2021 Category: Infectious Diseases Authors: John James Parker Rany Octaria Miranda D Smith Samantha J Chao Mary Beth Davis Celia Goodson Jon Warkentin Denise Werner Mary-Margaret A Fill Source Type: research

In Texas-Mexico Border Towns, COVID-19 Has Had an Unconscionably High Death Toll
Alfredo “Freddy” Valles was an accomplished trumpeter and a beloved music teacher for nearly four decades at one of the poorest middle schools in El Paso, Texas. He was known for buying his students shoes and bow ties for their band concerts, his effortlessly positive demeanor and his suave personal style—“he looked like he stepped out of a different era, the 1950s,” says his niece, Ruby Montana. While Valles was singular in life, his death at age 60 in February 2021 was part of a devastating statistic: He was one of thousands of deaths in Texas border counties—where coronavirus mortalit...
Source: TIME: Health - June 22, 2021 Category: Consumer Health News Authors: René Kladzyk, Phil Galewitz and Elizabeth Lucas | El Paso Matters and KHN Tags: Uncategorized COVID-19 Source Type: news

Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine
NEW BRUNSWICK, N.J., April 21, 2021 – Johnson & Johnson (the Company) today announced publication in the New England Journal of Medicine of primary data from the Phase 3 ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The publication of the primary analysis follows the topline efficacy and safety data announced in January, showing the trial met all primary and key secondary endpoints, and found that the Johnson & Johnson single-dose COVID-19 vaccine prevented hospitalization and death across all study participants ...
Source: Johnson and Johnson - April 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Epidemiology of asymptomatic and symptomatic Coronavirus Disease 2019 confirmed cases in the Emirate of Abu Dhabi, United Arab Emirates: Observational study
This study was conducted to describe demographics, clinical features, and outcomes of 3827 confirmed cases of Coronavirus Disease 2019 between March 12 and April 22, 2020 in the Emirates of Abu Dhabi, United Arab Emirates (UAE). Data were extracted from the Infectious Diseases Notification Surveillance System of the Department of Health. The descriptive analysis was done using Statistical Package for Social Sciences v26 and reported according to Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. We analyzed 3827 cases; 82% were men, 18% women, 14% UAE citizens, and 86% were of ot...
Source: Medicine - March 26, 2021 Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research

This County Tried to Ensure Racial Equity in COVID-19 Vaccinations. The State Said No
It takes about eight minutes to try and save a life. Or at least that’s how long it takes a volunteer with a tablet, standing in the parking lot at the T.R. Hoover Community Development center in South Dallas on a bitterly cold February morning. During the pandemic, the small nonprofit situated in the neighborhood that developers in the 1920s dubbed “the Ideal community” has taken on an ever evolving list of roles. It’s a job-search center. It’s a drive-through food pantry. And, of late, T.R. Hoover is an in-person coronavirus vaccine registration site aimed at helping Ideal’s mainly Bla...
Source: TIME: Health - March 2, 2021 Category: Consumer Health News Tags: Uncategorized COVID-19 feature Source Type: news

When a Texas County Tried to Ensure Racial Equity in COVID-19 Vaccinations, It Didn ’t Go as Planned
It takes about eight minutes to try and save a life. Or at least that’s how long it takes a volunteer with a tablet, standing in the parking lot at the T.R. Hoover Community Development center in South Dallas on a bitterly cold February morning. During the pandemic, the small nonprofit situated in the neighborhood that developers in the 1920s dubbed “the Ideal community” has taken on an ever evolving list of roles. It’s a job-search center. It’s a drive-through food pantry. And, of late, T.R. Hoover is an in-person coronavirus vaccine registration site aimed at helping Ideal’s mainly Bla...
Source: TIME: Health - March 2, 2021 Category: Consumer Health News Authors: Janell Ross/Dallas Tags: Uncategorized COVID-19 feature Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe COVID-...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news